HopeStage
Back to all studies
CompletedNCT01312272

Acute Intranasal Oxytocin and Social Cognition in Schizophrenia

About this titleRead the official source — NCT01312272
Medication studyAges 18–55United States
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Listed locations
Los AngelesSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2011
Recruitment status
Completed
Enrollment listed in the registry
24
Sponsor
VA Greater Los Angeles Healthcare System
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT01312272
Official title
Show the full official title

Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Los Angeles

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is VA Greater Los Angeles Healthcare System.

Did this study involve medication?

Yes. The study involved medication, including Oxytocin and Inactive placebo nasal spray.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies